Population screening for Wilson's disease

Annals of the New York Academy of Sciences

Volumn 1315, Issue 1, 2014, Pages 64-69

  Hahn, Si Houn ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

ATP7B; Ceruloplasmin; LC MRM MS; LC MS MS; Newborn screening; Population screening; Wilson's disease

Indexed keywords

BIOLOGICAL MARKER; CERULOPLASMIN; CHELATING AGENT; COPPER; MONOCLONAL ANTIBODY; WILSON DISEASE PROTEIN; ZINC DERIVATIVE;

ARTICLE; ATP7B GENE; BRAIN DAMAGE; DISABILITY; DNA DETERMINATION; DRIED BLOOD SPOT TESTING; EARLY DIAGNOSIS; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENE MUTATION; GENETIC SCREENING; HUMAN; LIQUID CHROMATOGRAPHY; LIVER CIRRHOSIS; MASS SCREENING; MONITORING; MULTIPLE REACTION MONITORING; NEUROLOGIC DISEASE; NEWBORN SCREENING; PROTEIN EXPRESSION; SIBLING; TANDEM MASS SPECTROMETRY; WILSON DISEASE;

ATP7B; CERULOPLASMIN; LC-MRM-MS; LC-MS/MS; NEWBORN SCREENING; POPULATION SCREENING; WILSON'S DISEASE;

ADENOSINE TRIPHOSPHATASES; ADOLESCENT; BIOLOGICAL MARKERS; CATION TRANSPORT PROTEINS; CERULOPLASMIN; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, LIQUID; CLINICAL TRIALS AS TOPIC; COPPER; EARLY DIAGNOSIS; HEPATOLENTICULAR DEGENERATION; HUMANS; INFANT; INFANT, NEWBORN; MASS SCREENING; MASS SPECTROMETRY; NEONATAL SCREENING; PEPTIDE FRAGMENTS;

EID: 84900025905     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12423     Document Type: Article

References (28)

1. Sak, W. 1912. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Brain 34: 295-509.
2. Ala, A., A.P. Walker, K. Ashkan, et al. 2007. Wilson's disease. Lancet. 369: 397-408.
3. Roberts, E.A. & M.L. Schilsky. 2008. Diagnosis and treatment of Wilson disease: an update. Hepatology. 47: 2089-2111.
4. Brewer, G.J. 2005. Neurologically presenting Wilson's disease: epidemiology, pathophysiology and treatment. CNS Drugs 19: 185-192.
5. I Matzuda, T.P. & N.A. Holtman. 1974. Determination of apoceruloplasmin by radioimmunoassay in nutritional copper deficiency, Menke's kinky hair syndrome, Wilson's disease and umbilical cord blood. Pediatrics. 8: 821-824.
6. Endo, F., K. Taketa, K. Nakamura, et al. 1994. Measurement of blood holoceruloplasmin by EIA using a mouse monoclonal antibody directed to holoceruloplasmin. Implication for mass screening of Wilson disease. J. Inherit. Metab. Dis. 17: 616-620.
7. Yamaguchi, Y., T. Aoki, S. Arashima, et al. 1999. Mass screening for Wilson's disease: results and recommendations. Pediatr. Int. 41: 405-408.
8. Ohura, T., D. Abukawa, H. Shiraishi, et al. 1999. Pilot study of screening for Wilson disease using dried blood spots obtained from children seen at outpatient clinics. J. Inherit. Metab. Dis. 22: 74-80.
9. Owada, M., K. Suzuki, M. Fukushi, et al. 2002. Mass screening for Wilson's disease by measuring urinary holoceruloplasmin. J. Pediatr. 140: 614-616.
10. Nakayama, K., M. Kubota, Y. Katoh, et al. 2008. Early and presymptomatic detection of Wilson's disease at the mandatory 3-year-old medical health care examination in Hokkaido Prefecture with the use of a novel automated urinary ceruloplasmin assay. Mol. Genet. Metab. 94: 363-367.
11. Hahn, S.H., S.Y. Lee, Y.J. Jang, et al. 2002. Pilot study of mass screening for Wilson's disease in Korea. Mol. Genet. Metab. 76: 133-136.
12. Kroll, C.A., M.J. Ferber, B.D. Dawson, et al. 2006. Retrospective determination of ceruloplasmin in newborn screening blood spots of patients with Wilson disease. Mol. Genet. Metab. 89: 134-138.
13. deWilde, A., K. Sadilkova, M. Sadilek, et al. 2008. Tryptic peptide analysis of ceruloplasmin in dried blood spots using liquid chromatography-tandem mass spectrometry: application to newborn screening. Clin. Chem. 54: 1961-1968.
14. Zappu, A., O. Magli, M.B. Lepori, et al. 2008. High incidence and allelic homogeneity of Wilson disease in 2 isolated populations: a prerequisite for efficient disease prevention programs. J. Pediatr. Gastroenterol. Nutr. 47: 334-338.
15. Bennett, J. & S.H Hahn. 2011. Clinical molecular diagnosis of Wilson disease. Semin. Liver Dis. 31: 233-238.
16. Bennett, J.T., K.B. Schwarz, P.D. Swanson & S.H Hahn. 2013. An exceptional family with three consecutive generations affected by Wilson disease. JIMD Rep. 10: 1-4.
17. Zappu, A., M.B. Lepori, S. Incollu, et al. 2010. Development of TaqMan allelic specific discrimination assay for detection of the most common Sardinian Wilson's disease mutations. Implications for genetic screening. Mol. Cell Probes. 24: 233-235.
18. Coffey, A.J., M. Durkie, S. Hague, et al. 2013. A genetic study of Wilson's disease in the United Kingdom. Brain 136: 1476-1487.
19. Kerfoot, S.A., S. Jung, K. Golob, et al. 2012. Tryptic peptide screening for primary immunodeficiency disease by LC/MS-MS. Proteomics Clin. Appl. 6: 394-402.
20. Whiteaker, J.R., L. Zhao, L. Anderson & A.G Paulovich. 2010. An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers. Mol. Cell. Proteomics. 9: 184-196.
21. Whiteaker, J.R., C. Lin, J. Kennedy, et al. 2011. A targeted proteomics-based pipeline for verification of biomarkers in plasma. Nat. Biotechnol. 29: 625-634.
22. Payne, A.S., E.J. Kelly & J.D. Gitlin. 1998. Functional expression of the Wilson disease protein reveals mislocalization and impaired copper-dependent trafficking of the common H1069Q mutation. Proc. Natl. Acad Sci. U. S. A. 95: 10854-10859.
23. van den Berghe, P.V., J.M. Stapelbroek, E. Krieger, et al. 2009. Reduced expression of ATP7B affected by Wilson disease-causing mutations is rescued by pharmacological folding chaperones 4-phenylbutyrate and curcumin. Hepatology 50: 1783-1795.
24. de Bie, P., B. van de Sluis, E. Burstein, et al. 2007. Distinct Wilson's disease mutations in ATP7B are associated with enhanced binding to COMMD1 and reduced stability of ATP7B. Gastroenterology 133: 1316-1326.
25. Merle, U., K.H. Weiss, C. Eisenbach, et al. 2010. Truncating mutations in the Wilson disease gene ATP7B are associated with very low serum ceruloplasmin oxidase activity and an early onset of Wilson disease. BMC Gastroenterol. 10: 8.
26. Vrabelova, S., O. Letocha, M. Borsky & L. Kozak. 2005. Mutation analysis of the ATP7B gene and genotype/phenotype correlation in 227 patients with Wilson disease. Mol. Genet. Metab. 86: 277-285.
27. Mendell, J.T., N.A. Sharifi, J.L. Meyers, et al. 2004. Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise. Nat. Genet. 36: 1073-1078.
28. Chang, Y.F., J.S. Imam & M.F Wilkinson. 2007. The nonsense-mediated decay RNA surveillance pathway. Annu. Rev. Biochem. 76: 51-74.